Skip to content
DataLookout
Menu

CASTLE-ZS-04NCT07829874

Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer.

StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Start date changed from estimate of Sep 20, 2026 to Oct 26, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Objective Response Rate (ORR)
Timeframe: 24 months

Secondary (7)

Disease control rate (DCR) evaluated by the investigator per Response Evaluation Criteria in Solid Tumors Version 1.1
Duration of Response (DOR) evaluated by the investigator per Response Evaluation Criteria in Solid Tumors Version 1.1
Time to Response (TTR) evaluated by the investigator per Response Evaluation Criteria in Solid Tumors Version 1.1
Progression Free Survival (PFS) evaluated by the investigator per Response Evaluation Criteria in Solid Tumors Version 1.1
Overall survival (OS) evaluated by the investigator per Response Evaluation Criteria in Solid Tumors Version 1.1
Show 2 moreShow less
Number of participants with treatment-related adverse events as assessed by CTCAE v5.0
Translational study

Arms and interventions

ICC-01Experimental

Intrahepatic cholangiocarcinoma (ICC) received QL1706 + lenvatinib

ICC-02Experimental

Intrahepatic cholangiocarcinoma (ICC) received QL1706 + lenvatinib+cryoablation

ECC-01Experimental

Extrahepatic cholangiocarcinoma (ECC) received QL1706 + lenvatinib

ECC-02Experimental

Extrahepatic cholangiocarcinoma (ECC) received QL1706 + lenvatinib +cryoablation

GBC-01Experimental

Gallbladder cancer (GBC) received QL1706 + lenvatinib

GBC-02Experimental

Gallbladder cancer (GBC) received QL1706 + lenvatinib+cryoablation

Drugs: QL1706 (Iparomlimab/Tuvonralimab), Lenvatinib

Procedures: Cryoablation

Sites

1 site in 1 country

  • Zhongshan Hospital, Fudan UniversityShanghai, Shanghai Municipality, China